bupropion has been researched along with flibanserin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeRogatis, LR | 1 |
| Lodise, NM | 1 |
1 review(s) available for bupropion and flibanserin
| Article | Year |
|---|---|
Hypoactive sexual desire disorder in women: treatment options beyond testosterone and approaches to communicating with patients on sexual health.
Topics: alpha-MSH; Antidepressive Agents, Second-Generation; Benzimidazoles; Bupropion; Complementary Therapies; Female; Health Behavior; Health Communication; Humans; Peptides, Cyclic; Piperazines; Purines; Receptors, Melanocortin; Reproductive Health; Serotonin Antagonists; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2013 |
1 other study(ies) available for bupropion and flibanserin
| Article | Year |
|---|---|
Consultation corner. The latest on female sexual health.
Topics: Adjuvants, Immunologic; Adult; Antidepressive Agents, Second-Generation; Atrophy; Benzimidazoles; Bupropion; Clinical Trials, Phase III as Topic; Dehydroepiandrosterone; Dopamine Uptake Inhibitors; Female; Gels; Humans; Libido; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Placebos; Postmenopause; Purines; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sulfones; Testosterone; United States; United States Food and Drug Administration; Vagina; Vasodilator Agents | 2010 |